Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stroke and cognition.

R N Kalaria1, C Ballard

  • 1CBV Group, Wolfson Research Centre, Newcastle General Hospital, Westgate Road, Newcastle upon Tyne NE4 6BE, United Kingdom. r.n.kalaria@ncl.ac.uk

Current Atherosclerosis Reports
|June 8, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular and lifestyle risk factors of mild cognitive impairment in UK veterans and non-veterans.

Occupational medicine (Oxford, England)·2024
Same author

CTAD Task Force Paper: Neuropsychiatric Symptoms in AD: Clinical Trials Targeting Mild Behavioral Impairment: A Report from the International CTAD Task Force.

The journal of prevention of Alzheimer's disease·2024
Same author

Rumination moderates the longitudinal associations of awareness of age-related change with depressive and anxiety symptoms.

Aging & mental health·2023
Same author

Using Digital Tools to Advance Alzheimer's Drug Trials During a Pandemic: The EU/US CTAD Task Force.

The journal of prevention of Alzheimer's disease·2021
Same author

Age-related neurochemical and behavioural changes in D409V/WT GBA1 mouse: Relevance to lewy body dementia.

Neurochemistry international·2019
Same author

Commentary: Opportunities for Combination Trials.

The journal of prevention of Alzheimer's disease·2019
Same journal

Overview of Novel Mechanisms in Obesity Pharmacotherapy and Implications for Cardiovascular Disease: A Narrative Review.

Current atherosclerosis reports·2026
Same journal

Artificial and Other Non-Nutritive Sweeteners, the Microbiome, and Cardiometabolic Health.

Current atherosclerosis reports·2026
Same journal

Single-cell Technologies in Atherosclerosis: Uncovering Cellular Heterogeneity, Mechanisms, and Therapeutic Opportunities.

Current atherosclerosis reports·2026
Same journal

Primary Prevention of Dyslipidemia: 10 Practice-Changing Takeaways from the 2026 ACC/AHA Multisociety Guideline.

Current atherosclerosis reports·2026
Same journal

Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.

Current atherosclerosis reports·2026
Same journal

Familial Hypercholesterolemia in Women: Diagnosis, Treatment, and Cardiovascular Outcomes Across the Lifespan.

Current atherosclerosis reports·2026
See all related articles

Stroke survivors, especially the elderly, face increased risks of cognitive impairment and dementia. Factors like stroke type, lesion location, and co-existing conditions influence severity, with cholinergic system function a potential therapeutic target.

Area of Science:

  • Neurology
  • Geriatrics
  • Cognitive Science

Background:

  • Cognitive impairment and dementia are significantly increased in elderly stroke survivors.
  • Up to 30% of stroke survivors may experience cognitive impairments within 3 months post-stroke, potentially confounded by pre-existing conditions.
  • Familial stroke syndromes, like CADASIL, are recognized for associated cognitive changes and dementia.

Purpose of the Study:

  • To review factors influencing cognitive impairment and dementia following stroke.
  • To identify predictors of post-stroke cognitive decline.
  • To explore potential therapeutic targets for post-stroke cognitive dysfunction.

Main Methods:

  • Literature review of studies on post-stroke cognitive impairment and dementia.

Related Experiment Videos

  • Analysis of factors predicting cognitive impairment severity.
  • Examination of biological and genetic factors influencing stroke outcome and cognition.

    • Main Results:

    • Stroke type, lesion characteristics, and co-existing neurodegenerative pathology predict cognitive impairment.
    • Aphasia, diabetes, atrial fibrillation, and depression exacerbate cognitive deficits and affect survival.
    • The role of genetic factors (Apolipoprotein E e4, ACE gene) in modifying cognitive outcomes remains unclear.

    Conclusions:

    • Post-stroke cognitive impairment is a significant concern, influenced by multiple clinical and biological factors.
    • Identifying and managing these factors is crucial for improving long-term outcomes.
    • Targeting the amelioration of cholinergic function presents a promising therapeutic avenue for post-stroke dementia.